FMC stock trades 0.03 percent above its Xetra close

Published on 10/10/2026 at 10:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

FMC stock is EUR 37.62 in weekend trading on October 10, 2026 versus EUR 37.61 at the prior close. A CEO change is set for October 12.

Key points in brief

FMC traded at EUR 37.62 in weekend trading at Lang & Schwarz.
The price was 0.03 percent above the EUR 37.61 close for October 9, 2026.
Shervin J. Korangy is scheduled to become CEO on October 12, 2026.

Trading-Floor mit großen Bildschirmen, die Xetra- und MDAX-Kurscharts der Gesundheitsbranche zeigen — Börsen-Editorial zeigt Trading-Floor mit Xetra- und MDAX-Charts, passend zu Fresenius Medical Care AG DE0005785802, Illustration mit AI erstellt.

FMC stock was EUR 37.62 in weekend trading at Lang & Schwarz at 10:39 a.m. CEST on October 10, 2026, 0.03 percent above its Xetra close of EUR 37.61 at Lang & Schwarz on October 9, 2026.

Market context: Market report DAX.

The week in figures

The weekend-trading price was EUR 37.62 at Lang & Schwarz. The reference close for the last Xetra trading day was EUR 37.61 on October 9, 2026, putting the current indication 0.03 percent above that level.

The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CEST is shown by the continuously updated real-time quote of FMC stock.

Chronology of the week

On October 7, 2026, Fresenius Medical Care announced that Shervin J. Korangy, 51, would become CEO and Chair of the Management Board effective October 12, 2026. He is set to succeed Helen Giza.

Dates of the coming week

October 12, 2026 is the scheduled start date for Korangy's tenure as CEO and Chair of the Management Board, according to the company's press release. The next Xetra session is also scheduled for October 12, 2026.